CAMP4 Therapeutics Corporation (CAMP) vs Eupraxia Pharmaceuticals Inc. (EPRX)
A side-by-side comparison of CAMP4 Therapeutics Corporation and Eupraxia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
EPRX
Eupraxia Pharmaceuticals Inc.
$7.74HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CAMP vs EPRX
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)EPRX +222.9% (+79.7%/yr)EPRX compounded faster over this window
Log scale — wide-divergence pair
CAMP EPRX
CAMP vs EPRX: by the numbers
- •EPRX is the larger company ($259M vs $249M market cap).
- •Both run net losses; EPRX's is the smaller (0.00% vs -2543.74% net margin).
Metrics side by side
Valuation
| Metric | CAMP | EPRX |
|---|---|---|
| P/S ratio | 58.94 | N/A |
| P/B ratio | N/A | 2.55 |
Profitability
| Metric | CAMP | EPRX |
|---|---|---|
| Gross margin | 53.14% | 0.00% |
| Operating margin | -1488.31% | 0.00% |
| Net margin | -2543.74% | 0.00% |
| ROE | N/A | -38.33% |
| ROIC | -69.76% | -43.56% |
Growth (annualized)
| Metric | CAMP | EPRX |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.